What is JBIO stock price today?

JBIO (Jade Biosciences Inc) stock is trading at $22.85 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is JBIO stock going up or down today?

JBIO stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy JBIO stock now?

The decision to buy JBIO depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is JBIO a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for JBIO based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is JBIO stock overvalued or undervalued?

Use our DCF valuation calculator to determine if JBIO is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is JBIO's P/E ratio?

P/E ratio data for JBIO will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is JBIO's market cap?

JBIO (Jade Biosciences Inc) has a market capitalization of $1.13 billion, making it a small-cap stock.

What is JBIO's price to book ratio?

JBIO trades at a price-to-book (P/B) ratio of 3.39, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does JBIO pay dividends?

JBIO does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is JBIO's dividend yield?

JBIO does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is JBIO stock a good long-term investment?

JBIO's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is JBIO's revenue growth rate?

Revenue growth data for JBIO is available on our dashboard with detailed financial statement analysis.

Profitability metrics for JBIO are available on our dashboard with complete income statement analysis.

What are the risks of investing in JBIO?

Key risks for JBIO include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does JBIO compare to its competitors?

Compare JBIO to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize JBIO's performance and positioning.

What is JBIO's stock price target for 2026?

Our AI model provides price targets for JBIO based on fundamental analysis: Bull case $29.71 (+30%), Base case $26.28 (+15%), Bear case $20.57 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about JBIO?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for JBIO. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is JBIO's next earnings report?

JBIO reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

JBIO - Jade Biosciences Inc

NYSE * Health Care * Biotechnology

$22.85

+$0.97 (+4.43%)

About Jade Biosciences Inc

Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts.

JBIO Key Statistics

Market Cap

$1.13B

P/B Ratio

3.39

EPS

$-3.19

Employees

How JBIO Compares to Peers

JBIO is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
JBIO(This stock)	$1.13B	N/A	0%	0.0%	-
AMGNAmgen Inc	$191.53B	24.6	0%	0.2%	vs AMGN
GILDGilead Sciences	$170.84B	20.3	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$112.22B	28.8	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$79.35B	18.1	0%	0.3%	vs REGN
BIIBBiogen Inc	$26.03B	20.0	-0%	0.1%	vs BIIB

Jade Biosciences Inc Company Information

Headquarters: Massachusetts; U.S.A
Website: jadebiosciences.com
Sector: Health Care
Industry: Biotechnology

Data Updated: April 19, 2026 at 5:12 PM EDT

Ready to invest in JBIO?

Commission-free trading available. Affiliate links.

JBIO Lician Score

5% confidence

4.0/10

Neutral

JBIO has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates JBIOacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

JBIO Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for JBIO

Dashboard

Enter a ticker to analyze